Article ; Online: Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction.
2021 Volume 11, Issue 1, Page(s) 21462
Abstract: ... To confirm whether HO-1 suppresses SARS-CoV-2 infection, we assessed the antiviral activity of hemin ... an effective and safe HO-1 inducer, in SARS-CoV-2 infection. We found that treatment with hemin efficiently ... hemin indirectly increased the expression of interferon-stimulated proteins known to restrict SARS-CoV-2 ...
Abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease-19 (COVID-19). More than 143 million cases of COVID-19 have been reported to date, with the global death rate at 2.13%. Currently, there are no licensed therapeutics for controlling SARS-CoV-2 infection. The antiviral effects of heme oxygenase-1 (HO-1), a cytoprotective enzyme that inhibits the inflammatory response and reduces oxidative stress, have been investigated in several viral infections. To confirm whether HO-1 suppresses SARS-CoV-2 infection, we assessed the antiviral activity of hemin, an effective and safe HO-1 inducer, in SARS-CoV-2 infection. We found that treatment with hemin efficiently suppressed SARS-CoV-2 replication (selectivity index: 249.7012). Besides, the transient expression of HO-1 using an expression vector also suppressed the growth of the virus in cells. Free iron and biliverdin, which are metabolic byproducts of heme catalysis by HO-1, also suppressed the viral infection. Additionally, hemin indirectly increased the expression of interferon-stimulated proteins known to restrict SARS-CoV-2 replication. Overall, the findings suggested that HO-1, induced by hemin, effectively suppressed SARS-CoV-2 in vitro. Therefore, HO-1 could be potential therapeutic candidate for COVID-19. |
---|---|
MeSH term(s) | Animals ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/virology ; Cell Survival/drug effects ; Chlorocebus aethiops ; Heme Oxygenase-1/antagonists & inhibitors ; Heme Oxygenase-1/genetics ; Heme Oxygenase-1/metabolism ; Hemin/chemistry ; Hemin/pharmacology ; Hemin/therapeutic use ; Humans ; RNA Interference ; RNA, Small Interfering/metabolism ; RNA, Viral/metabolism ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; SARS-CoV-2/physiology ; Up-Regulation/drug effects ; Vero Cells ; Virus Replication/drug effects ; COVID-19 Drug Treatment |
Chemical Substances | Antiviral Agents ; RNA, Small Interfering ; RNA, Viral ; Hemin (743LRP9S7N) ; Heme Oxygenase-1 (EC 1.14.14.18) |
Language | English |
Publishing date | 2021-11-02 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2615211-3 |
ISSN | 2045-2322 ; 2045-2322 |
ISSN (online) | 2045-2322 |
ISSN | 2045-2322 |
DOI | 10.1038/s41598-021-01054-3 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.